Prot #VX12-970-001: An Open-Label, First-in-Human Study of the Safety, Tolerability, and Pharmacokinetics of VX-970 in Combination With Cytotoxic Chemotherapy in Subjects With Advanced Solid Tumors

Project: Research project

Project Details

StatusFinished
Effective start/end date5/16/16 → 5/16/19

Funding

  • Quintiles, Inc. (Prot #VX12-970-001 // Prot #VX12-970-001)
  • Vertex Pharmaceuticals Incorporated (Prot #VX12-970-001 // Prot #VX12-970-001)